King Pharmaceuticals Settles Shareholder Suit
King Pharmaceuticals Inc. has agreed to pay $13.5 million in legal fees and make changes to its corporate governance to settle a shareholder derivative lawsuit that accused the company of breaching...To view the full article, register now.
Already a subscriber? Click here to view full article